HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: 285/4/L964    most recent 00171.2003v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (6) Citing Articles via Google Scholar Google Scholar Articles by O'Reilly, M. A. Articles by Maniscalco, W. M. Search for Related Content PubMed PubMed Citation Articles by O'Reilly, M. A. Articles by Maniscalco, W. M.

Induced p21^Cip1 in premature baboons with CLD: implications for alveolar hypoplasia

Department of Pediatrics, School of Medicine and Dentistry, The University of Rochester, Rochester New York 14642

Submitted 29 May 2003 ; accepted in final form 12 July 2003

Aberrant pulmonary epithelial and mesenchymal cell proliferation occurs when newborns are treated with oxygen and ventilation to mitigate chronic lung disease. Because the cyclin-dependent kinase inhibitor p21 inhibits proliferation of oxygen-exposed cells, its expression was investigated in premature baboons delivered at 125 days (67% of term) and treated with oxygen and ventilation pro re nata (PRN) for 2, 6, 14, and 21 days. Approximately 5% of all cells expressed p21 during normal lung development of which <1% of these cells were pro-surfactant protein (SP)-B-positive epithelial cells. The percentage of cells expressing p21 increased threefold in all PRN-treated animals, but different cell populations expressed it during disease progression. Between 2 and 6 days of treatment, p21 was detected in 30-40% of pro-SP-B cells. In contrast, only 12% of pro-SP-B cells expressed p21 by 14 and 21 days of treatment, by which time p21 was also detected in mesenchymal cells. Even though increased epithelial and mesenchymal cell proliferation occurs during disease progression, those cells expressing p21 did not also express the proliferative marker Ki67. Thus two populations of epithelial and mesenchymal cells can be identified that are either expressing Ki67 and proliferating or expressing p21 and not proliferating. These data suggest that p21 may play a role in disorganized proliferation and alveolar hypoplasia seen in newborn chronic lung disease.

bronchopulmonary dysplasia; cell proliferation; development; epithelium; oxygen; chronic lung disease

This article has been cited by other articles:

				D. Irwin, K. Helm, N. Campbell, M. Imamura, K. Fagan, J. Harral, M. Carr, K. A. Young, D. Klemm, S. Gebb, et al. Neonatal lung side population cells demonstrate endothelial potential and are altered in response to hyperoxia-induced lung simplification Am J Physiol Lung Cell Mol Physiol, October 1, 2007; 293(4): L941 - L951. [Abstract] [Full Text] [PDF]

				R. L. Auten, S. N. Mason, M. H. Whorton, W. R. Lampe, W. M. Foster, R. N. Goldberg, B. Li, J. S. Stamler, and K. M. Auten Inhaled Ethyl Nitrite Prevents Hyperoxia-impaired Postnatal Alveolar Development in Newborn Rats Am. J. Respir. Crit. Care Med., August 1, 2007; 176(3): 291 - 299. [Abstract] [Full Text] [PDF]

				R. L. Auten, M. A. O'Reilly, T. D. Oury, E. Nozik-Grayck, and M. H. Whorton Transgenic extracellular superoxide dismutase protects postnatal alveolar epithelial proliferation and development during hyperoxia Am J Physiol Lung Cell Mol Physiol, January 1, 2006; 290(1): L32 - L40. [Abstract] [Full Text] [PDF]

				S. A. McGrath-Morrow, C. Cho, S. Soutiere, W. Mitzner, and R. Tuder The Effect of Neonatal Hyperoxia on the Lung of p21Waf1/Cip1/Sdi1-Deficient Mice Am. J. Respir. Cell Mol. Biol., May 1, 2004; 30(5): 635 - 640. [Abstract] [Full Text] [PDF]